Vinogradov IV, Gamidov SI, Gabliya MY, et al
That comes from a different trial: the Phase 1 single-dose study in lean participants, where -hydroxybutyrate started below the assays detection floor and reached 708 mol/L at 4.5 mg by day 8 a large, dose-ordered rise in a lean cohort. The MASLD substudy, by contrast, found ketones moving only at 4 mg and above in a group with insulin resistance damping the readout
Kern JK, Geier DA, Adams JB, Mehta JA, Grannemann BD, Geier MR (2011) Toxicity biomarkers in autism spectrum disorder: a blinded study of urinary porphyrins
Both BPC-157 and TB500 are of interest in preclinical research for their potential to support recovery from injuries affecting muscles, ligaments, and other connective tissues